SENATE - Louisiana
SENATE - Louisiana
SENATE - Louisiana
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Page 40 <strong>SENATE</strong><br />
June 21, 2004<br />
2. That the Senate Floor Amendments proposed by Senator<br />
Marionneaux and adopted by the Senate on June 16, 2004, be<br />
rejected.<br />
3. That the following amendments to the reengrossed bill be<br />
adopted:<br />
AMENDMENT NO. 1<br />
On page 2, line 16, after "Act" delete the comma "," and delete the<br />
remainder of the line and delete line 17 and at the beginning of line 18,<br />
delete "mail"<br />
AMENDMENT NO. 2<br />
On page 2, line 21, after "18:1511.5." insert ""Outstanding fine, fee,<br />
or penalty" shall not mean any fine, fee, or penalty which has been<br />
paid in full or for which the candidate is in compliance with a<br />
payment plan established in writing bet ween the Supervisory<br />
Committee on Campaign Finance Disclosure and the candidate."<br />
Representatives:<br />
Carla Blanchard Dartez<br />
Representative Charles D. Lancaster, Jr.<br />
Representative M.J. "Mert" Smiley<br />
Rules Suspended<br />
Respectfully submitted,<br />
Senators:<br />
Reggie Dupre<br />
Robert Marionneaux, Jr.<br />
Charles D. Jones<br />
Senator Marionneaux asked for and obtained a suspension of the<br />
rules for the purpose of considering the Conference Committee<br />
Report. On motion of Senator Marionneaux, a vote was taken on the<br />
adoption of the report.<br />
ROLL CALL<br />
The roll was called with the following result:<br />
YEAS<br />
Mr. President Duplessis Kostelka<br />
Adley Dupre Lentini<br />
Amedee Ellington Malone<br />
Bajoie Fontenot Marionneaux<br />
Barham Gautreaux, B McPherson<br />
Boasso Gautreaux, N Michot<br />
Boissiere Hainkel Nevers<br />
Cain Heitmeier Romero<br />
Chaisson Holden Smith<br />
Cheek Hollis Theunissen<br />
Cravins Irons Ullo<br />
Dardenne<br />
Jones<br />
Total—35<br />
NAYS<br />
Fields<br />
Total—1<br />
ABSENT<br />
Jackson Mount Schedler<br />
Total—3<br />
50th DAY'S PROCEEDINGS<br />
The Chair declared the Conference Committee Report was<br />
adopted. Senator Marionneaux moved to reconsider the vote by<br />
which the report was adopted and laid the motion on the table.<br />
CONFERENCE COMMITTEE REPORT<br />
House Bill No. 1701 By Representative Durand<br />
June 18, 2004<br />
To the Honorable Speaker and Members of the House of<br />
Representatives and the Honorable President and Members of the<br />
Senate.<br />
Ladies and Gentlemen:<br />
We, the conferees appointed to confer over the disagreement<br />
between the two houses concerning House Bill No. 1701 by<br />
Representative Durand, recommend the following concerning the<br />
engrossed bill:<br />
1. That Senate Floor Amendments Nos. 1 and 2 proposed by<br />
Senator Holden and adopted by the Senate on June 14, 2004, be<br />
adopted.<br />
2. That Senate Floor Amendment No. 3 proposed by Senator<br />
Holden and adopted by the Senate on June 14, be rejected.<br />
3. That the following amendments to the engrossed bill be adopted:<br />
AMENDMENT NO. 1<br />
On page 5, line 17, delete the word "urine"<br />
AMENDMENT NO. 2<br />
On page 6, line 8, delete the word "urine"<br />
AMENDMENT NO. 3<br />
On page 6, line 9, delete the word "urine"<br />
AMENDMENT NO. 4<br />
On page 6, between lines 21 and 22, insert the following:<br />
"J. This Chapter does not preclude an employer or an<br />
employer's agent from utilizing a USFDA cleared specimen testing<br />
method that uses a sample as defined in R.S. 49:1001 provided that<br />
such sample is processed in a laboratory with a SAMHSA<br />
certification using generally accepted cutoff levels as established by<br />
the USFDA for a saliva or oral fluid testing product, or by SAMHSA<br />
at such time when SAMHSA implements a final rule to regulate<br />
saliva or oral fluid testing. Any saliva or oral fluid sample collected<br />
shall be subject to USFDA-cleared immunoassay screening and<br />
confirmation testing at a SAMHSA certified laboratory. Such<br />
samples that test positive shall be preserved by the laboratory and<br />
available for challenge testing at the request of the donor. No sample<br />
shall be used to collect or analyze DNA."<br />
AMENDMENT NO. 5<br />
On page 6, delete line 24 in its entirety<br />
AMENDMENT NO. 6<br />
On page 6, line 25, delete "49:1008," and insert "A. All drug testing"<br />
Respectfully submitted,<br />
2142